Implantation of an endoscopically deployed duodenal-jejunal bypass Liner (DJBL) in obese type 2 diabetes subjects-12 months follow up of eight subjects

被引：0
|
作者：
Stratmann, B. [1 ]
Krepak, Y. [1 ]
Hauber, M. [1 ]
Lee-Barkey, Y. H. [1 ]
Fischer, M. [1 ]
Diethelm, T. [1 ]
机构：
[1] Herz & Diabet Zentrum NRW, Diabet Zentrum, Bad Oeynhausen, Germany
来源：
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES | 2014年 / 122卷 / 03期
关键词：
D O I：
10.1055/s-0034-1372121
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P104
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Six Month Results of a Multi-Center, Prospective, Randomized Trial of the Endoscopic Duodenal-Jejunal Bypass Liner for the Treatment of Type 2 Diabetes in Obese Subjects
    Koehestanie, Parweez
    Meesters, Berry
    Janssen, Ignace
    Bouvy, Nicole
    Greve, Jan Willem
    DIABETES, 2012, 61 : A305 - A305
  • [22] Clinical follow-up on weight loss, glycemic control, and safety aspects of 24 months of duodenal-jejunal bypass liner implantation
    B. Betzel
    M. I. Cooiman
    E. O. Aarts
    I. M. C. Janssen
    P. J. Wahab
    M. J. M. Groenen
    J. P. H. Drenth
    F. J. Berends
    Surgical Endoscopy, 2020, 34 : 209 - 215
  • [23] Clinical follow-up on weight loss, glycemic control, and safety aspects of 24 months of duodenal-jejunal bypass liner implantation
    Betzel, B.
    Cooiman, M. I.
    Aarts, E. O.
    Janssen, I. M. C.
    Wahab, P. J.
    Groenen, M. J. M.
    Drenth, J. P. H.
    Berends, F. J.
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2020, 34 (01): : 209 - 215
  • [24] CD163+and CD206+adipose tissue immune cells in obese subjects with type 2 diabetes mellitus: the effect of gastric plication and duodenal-jejunal bypass liner implantation
    Cinkajzlova, A.
    Lacinova, Z.
    Klouckova, J.
    Kavalkova, P.
    Trachta, P.
    Mraz, M.
    Haluzik, M.
    DIABETOLOGIA, 2015, 58 : S49 - S49
  • [25] Endoscopic Duodenal-Jejunal Bypass Liner (EndoBarrier®) for the treatment of type 2 diabetes mellitus
    Laubner, K.
    Perakakis, N.
    Potasso, L.
    Schwacha, H.
    Seufert, J.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2014, 122 (03)
  • [26] Six Months of Treatment with the Endoscopic Duodenal-Jejunal Bypass Liner Does Not Lead to Decreased Systemic Inflammation in Obese Patients with Type 2 Diabetes
    Charlotte de Jonge
    Sander S. Rensen
    Hedwig M. A. D’Agnolo
    Nicole D. Bouvy
    Wim A. Buurman
    Jan Willem M. Greve
    Obesity Surgery, 2014, 24 : 337 - 341
  • [27] Six Months of Treatment with the Endoscopic Duodenal-Jejunal Bypass Liner Does Not Lead to Decreased Systemic Inflammation in Obese Patients with Type 2 Diabetes
    de Jonge, Charlotte
    Rensen, Sander S.
    D'Agnolo, Hedwig M. A.
    Bouvy, Nicole D.
    Buurman, Wim A.
    Greve, Jan Willem M.
    OBESITY SURGERY, 2014, 24 (02) : 337 - 341
  • [28] Weight Loss and Metabolic Improvement in Morbidly Obese Subjects Implanted for 1 Year With an Endoscopic Duodenal-Jejunal Bypass Liner
    Escalona, Alex
    Pimentel, Fernando
    Sharp, Allan
    Becerra, Pablo
    Slako, Milenko
    Turiel, Dannae
    Munoz, Rodrigo
    Bambs, Claudia
    Guzman, Sergio
    Ibanez, Luis
    Gersin, Keith
    ANNALS OF SURGERY, 2012, 255 (06) : 1080 - 1085
  • [29] Radiographic appearance of endoscopic duodenal-jejunal bypass liner for treatment of obesity and type 2 diabetes
    Levine, Andy
    Ramos, Almino
    Escalona, Alex
    Rodriguez, Leonardo
    Greve, Jan Willem
    Janssen, Ignace
    Rothstein, Richard
    Nepomnayshy, Dmitry
    Gersin, Keith S.
    Melanson, David
    Lamport, Ronald
    Fishman, Ezra
    Malomo, Kenneth
    Kaplan, Lee M.
    Galvao Neto, Manoel
    SURGERY FOR OBESITY AND RELATED DISEASES, 2009, 5 (03) : 371 - 374
  • [30] The Duodenal-Jejunal Bypass Liner for the Treatment of Type 2 Diabetes Mellitus and/or Obesity: a Systematic Review
    Zechmeister-Koss, Ingrid
    Huic, Mirjana
    Fischer, Stefan
    OBESITY SURGERY, 2014, 24 (02) : 310 - 323
12345